ENDS EVALI VALI THCVALI: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<br> | <br> | ||
<big>'''“E-cigarette or Vaping Product Use-Associated Lung Injury” (EVALI) -- Right Illness, Wrong Name. Will The CDC Correct It?'''</big> | <big>'''“E-cigarette or Vaping Product Use-Associated Lung Injury” (EVALI) -- Right Illness, Wrong Name. Will The CDC Correct It?'''</big> | ||
<br> | |||
<br> | <br> | ||
The 2019–2020 outbreak of acute lung injuries in the United States represents a pivotal juncture in modern public health communication. Designated by the Centers for Disease Control and Prevention (CDC) as EVALI (E-cigarette, or Vaping, Product Use-Associated Lung Injury), the nomenclature explicitly embeds commercial electronic nicotine delivery systems (ENDS) into the medical definition of the disease. This was maintained despite definitive clinical and epidemiological evidence identifying vitamin E acetate—a cutting agent exclusive to illicit, black-market tetrahydrocannabinol (THC) cartridges—as the primary causative agent. | The 2019–2020 outbreak of acute lung injuries in the United States represents a pivotal juncture in modern public health communication. Designated by the Centers for Disease Control and Prevention (CDC) as EVALI (E-cigarette, or Vaping, Product Use-Associated Lung Injury), the nomenclature explicitly embeds commercial electronic nicotine delivery systems (ENDS) into the medical definition of the disease. This was maintained despite definitive clinical and epidemiological evidence identifying vitamin E acetate—a cutting agent exclusive to illicit, black-market tetrahydrocannabinol (THC) cartridges—as the primary causative agent. | ||